Oriol Casanovas, Douglas Hanahan and colleagues studied the response to VEGFA–VEGFR2 pathway inhibition of pancreatic neuroendocrine cancer in the RIP1-Tag2 mouse model and glioblastoma ...

There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

Researchers at the University of Michigan's Rogel and Blondy Pancreatic Cancer ... of traditional progression model in which all of these eventually turn into cancer. Otherwise, pancreas cancer ...

The researchers found that administering 75 grams of vitamin C three times a week doubled overall survival rates of patients with late-stage metastatic pancreatic cancer from eight months to 16 ...

A new prediction model for infected pancreatic necrosis (IPN) in patients with acute pancreatitis (AP) offers a groundbreaking approach to improving patient outcomes. Developed by a team of ...

A new prediction model for infected pancreatic necrosis (IPN) in patients with acute pancreatitis (AP) offers a groundbreaking approach to improving patient outcomes.

Short-Course Adjuvant Vaginal Cuff Brachytherapy in Early Endometrial Cancer Compared with Standard of Care (SAVE): A Randomized Clinical Trial Pancreatic ductal adenocarcinoma (PDAC) is the third ...

A new prediction model for infected pancreatic necrosis (IPN) in patients with acute pancreatitis (AP) offers a groundbreaking approach to improving patient outcomes. Developed by a team of ...

Pancreatic cancer is one of the rarest cancers worldwide. It occurs when the cells in the pancreas, an organ in the abdomen that plays a role in digestion and hormone production, start to grow ...

A tumor marker for pancreatic cancer helps healthcare professionals detect, diagnose, or treat it. However, a person can have high tumor marker levels without having cancer. Tumor markers are ...

The FDA has granted accelerated approval to zenocutuzumab, a new drug for adults with advanced non-small-cell lung cancer (NSCLC) or pancreatic cancer. The drug is the first comprehensive ...